Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review

Anticoagulation therapy is the first line and drug of choice for both the treatment and prophylaxis of venous thromboembolism (deep vein thrombosis and/or pulmonary embolism). Anticoagulation drugs, ranging from different preparations of heparin, warfarin, and newer direct oral drugs such as rivarox...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, Peter, Visagan, Shakthi, Issa, Reem, Gorantla, Vasavi Rakesh, Thomas, Sneha E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608253/
https://www.ncbi.nlm.nih.gov/pubmed/34853735
http://dx.doi.org/10.7759/cureus.18992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608253/
https://www.ncbi.nlm.nih.gov/pubmed/34853735
http://dx.doi.org/10.7759/cureus.18992

Ejemplares similares